Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: A multicenter retrospective study

Transplantation

Volumn 70, Issue 1, 2000, Pages 112-116

  Grossi, Paolo ^a   Farina, Claudio ^b   Fiocchi, Roberto ^b   Gasperina, Daniela Dalla ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Azienda Ospedaliera Ospedali R   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; BRONCHITIS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDIASIS; CRYPTOCOCCUS NEOFORMANS; ESOPHAGITIS; FEMALE; FUNGAL MENINGITIS; GASTRITIS; HEART LUNG TRANSPLANTATION; HUMAN; LUNG ASPERGILLOSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOULD; PREVALENCE; PRIORITY JOURNAL; RECIPIENT; RHIZOPUS; SPOROTHRIX; SYSTEMIC MYCOSIS; TRICHOSPORON BEIGELII;

ADULT; AGED; FEMALE; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES;

EID: 0034662016     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Grossi P, De Maria R, Caroli A, Zaina MS, Minoli L. Infection in heart transplant recipients: the experience of the Italian heart transplantation program. J Heart Lung Transplant 1992; 11: 847.
2. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16: 677.
3. Fishman JA, Rubin RH. Fungal infection in the organ transplant recipient: challenges and opportunities. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin Heidelberg: Springer-Verlag; 1996: 555.
4. Dummer JS, Montero CG, Griffith BP, Hardesty RL, Paradis IL, Ho M. Infections in heart-lung transplant recipients. Transplantation 1986; 41: 725.
5. Dauber JS, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990; 11: 291.
6. Keating MR, Guerrero MA, Daly RC, Walker RC, Davies SF. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest 1996; 109: 1119.
7. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310.
8. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781.
9. Dowling RD, Balandi N, Zenati M, et al. Disruption of the aortic anastomosis after heart-lung transplantation. Ann Thorac Surg 1990; 49: 118.
10. Stringer JR, Edman JC, Cushion MT, Richards FF, Watanabe J. The fungal nature of Pneumocystis. J Med Vet Mycol 1992; 30(S1): 271.
11. Cushion MT, Harmsen A, Matsumoto Y, Stringer JR, Wakefield AE, Yamada M. Recent advances in the biology of Pneumocystis carinii. J Med Vet Mycol 1994; 32(S1): 217.
12. Gerna G, Revello MG, Percivalle E, Morini F. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 1992; 30: 1232.
13. Gerna G, Revello MG, Percivalle E, Zavattoni M, Parea M, Battaglia M. Quantitation of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 1990; 28: 2681.
14. Ljungman P, Plotkin SA. Workshop on CMV disease: definitions, clinical severity scores, and new syndromes. Scand J Infect Dis 1995; 99: 87.
15. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587.
16. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 Working Formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 1996; 15: 1.
17. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987; 106: 209.
18. Linder J. Infection as a complication of heart transplantation. J Heart Transplant 1988; 7: 390.
19. Tambini R, Farina C, Fiocchi R, et al. Possible pathogenic role of Sporothrix cyanescens isolated from a lung lesion in a heart transplant patients. J Med Vet Mycol 1996; 34: 195.
20. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171.
21. Paradowski LJ. Saprophytic fungal infections and lung transplantation: revisited. J Heart Lung Transplant 1997; 16: 524.
22. Yeldandi V, Laghi F, McCabe MA, et al. Aspergillus and lung transplantation. J Heart Lung Transplant 1995; 14: 883.
23. Maertens J, VerHaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223.
24. Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis for systemic candidiasis. J Clin Microbiol 1999; 37: 1510.
25. Marco F, Pfaller MA, Messer SA, Jones RN. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol 1998; 36(6): 433.
26. Johnson EM, Szekely A, Warnock DW. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998; 42(6): 741.